Regulatory Articles. App Notes, Case Studies. & White Papers

  1. Navigating IND Submissions In China

    Lonza Biologics recently presented a webinar on how to navigate the complexities of submitting a clinical trial application in China.

  2. The Importance Of Assessing And Mitigating Immunogenicity Potential

    Immunogenicity assessment is an area where "standard" in vivo toxicology assessments might lack clinical relevance. Get an expert view on early immunosafety assessment challenges and risk mitigation strategies.